Armistice Capital’s Elevation Oncology ELEV Stock Holding History

Armistice Capital’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750,000	Closed	-$497K	–	325
2023 Q3	$497K	Sell	750,000 -1,646,000	-69%	-$1.66M	0.01%	168
2023 Q2	$3.64M	Buy	+2,396,000	New	+$6.32M	0.09%	126

Other funds holding ELEV

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return